Built alongside auditors and industry experts, the new solution sets a new benchmark for financial transparency, compliance, ...
ROCKVILLE, MARYLAND / ACCESS Newswire / March 10, 2026 / Theralogix, a trusted leader in evidence-based nutritional supplements, is proud to announce the launch of OvaNAD+ , a science-driven ...
Zug, Switzerland--(Newsfile Corp. - March 9, 2026) - Strategic discussions are underway to strengthen collaboration between Sweden and Japan in sustainable innovation, life sciences, and ...
CALGARY, Alberta, March 09, 2026 (GLOBE NEWSWIRE) -- De Havilland Aircraft of Canada (De Havilland Canada) is pleased to provide an update on the De Havilland Canadair 515 (DHC-515) currently in ...
CANBERA (dpa-AFX) - Asian stock markets are trading mostly higher on Tuesday, following the broadly positive cues from Wall Street overnight, as traders react to positive reports of U.S. President ...
KAWASAKI, Japan, Mar 10, 2026 - (JCN Newswire) - Fujitsu Limited today announced the launch of the Fujitsu Accelerator Program for Defense Tech, a collaborative program aimed at fostering innovation ...
ESGL Holdings Limited (NASDAQ: ESGL) (the "Company"), today announced its corporate name change from ESGL Holdings Limited to ...
FORT PIERCE, FL / ACCESS Newswire / March 9, 2026 / Twin Vee PowerCats Co. (NASDAQ:VEEE), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced ...
HAMILTON, ONTARIO / ACCESS Newswire / March 9, 2026 / Structured Restoration has received the 2026 Consumer Choice Award in ...
The Arovy Data Dictionary now features Bulk AI Documentation and a new API, helping teams turn Salesforce metadata into a trusted foundation for analytics, automation, and AI. ATLANTA, GA / ACCESS New ...
VANCOUVER, BC / ACCESS Newswire / March 9, 2026 / FutureGen Industries Corp. (formerly Right Season Investments Corp.) (TSXV:LITT)(Frankfurt:T500, WKN:A41WY4) ("FutureGen Industries" or the "Company") ...
The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...